Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) FCF Margin (2018 - 2025)

Abvc Biopharma (ABVC) has disclosed FCF Margin for 11 consecutive years, with 14087.32% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 4980115.0% year-over-year to 14087.32%, compared with a TTM value of 698.7% through Dec 2025, down 34368.0%, and an annual FY2025 reading of 9397.08%, down 904206.0% over the prior year.
  • FCF Margin was 14087.32% for Q4 2025 at Abvc Biopharma, up from 121.2% in the prior quarter.
  • Across five years, FCF Margin topped out at 14087.32% in Q4 2025 and bottomed at 79320.83% in Q1 2024.
  • Average FCF Margin over 5 years is 7856.76%, with a median of 1135.36% recorded in 2023.
  • The sharpest move saw FCF Margin tumbled -7815329bps in 2024, then soared 7955059bps in 2025.
  • Year by year, FCF Margin stood at 6680.12% in 2021, then plummeted by -101bps to 78.3% in 2022, then plummeted by -25294bps to 19882.82% in 2023, then plummeted by -80bps to 35713.84% in 2024, then soared by 139bps to 14087.32% in 2025.
  • Business Quant data shows FCF Margin for ABVC at 14087.32% in Q4 2025, 121.2% in Q3 2025, and 690.95% in Q2 2025.